Comparison of the Efficacy and Safety of Three Intravenous Immunoglobulin Brands in Pediatric Patients with Primary Immunodeficiency

被引:0
|
作者
Engchuan, Vorapan [1 ]
Yuenyongviwat, Araya [2 ]
Sangsupawanich, Pasuree [3 ]
机构
[1] Prince Songkla Univ, Hat Yai, Thailand
[2] Prince Songkla Univ, Hat Yai, Thailand
[3] Prince Songkla Univ, Hat Yai, Thailand
关键词
D O I
10.1016/j.jaci.2015.12.872
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
737
引用
收藏
页码:AB226 / AB226
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of human intravenous immunoglobulin 5% (Ig VENA) in pediatric patients affected by primary immunodeficiency
    Ricci, Silvia
    Lippi, Francesca
    Canessa, Clementina
    Guarnieri, Chiara
    Macchia, Roberta
    Azzari, Chiara
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2020, 34
  • [2] Efficacy and tolerability of an Argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases
    Krasovec, S.
    Ornani, A.
    Oleastro, M.
    Rosenzweig, S.
    Roy, A.
    Perez, L.
    Campos, G.
    Marin, N.
    Martinez, A.
    Mahieu, C.
    Manfredi, M. J.
    Sisti, A.
    Zelazko, M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (02) : 227 - 232
  • [3] Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases
    S. Krasovec
    A. Ornani
    M. Oleastro
    S. Rosenzweig
    A. Roy
    L. Perez
    G. Campos
    N. MarÍn
    A. Martinez
    C. Mahieu
    M. J. Manfredi
    A. Sisti
    M. Zelazko
    Journal of Clinical Immunology, 2007, 27 : 227 - 232
  • [4] Efficacy and safety of intravenous immunoglobulin in patients with common variable immunodeficiency
    Sousa, M. J.
    Guilherme, A.
    Moreira da Silva, J. P.
    ALLERGY, 2013, 68 : 504 - 504
  • [5] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Wasserman, Richard L.
    Church, Joseph A.
    Stein, Mark
    Moy, James
    White, Martha
    Strausbaugh, Steven
    Schroeder, Harry
    Ballow, Mark
    Harris, James
    Melamed, Isaac
    Elkayam, David
    Lumry, William
    Suez, Daniel
    Rehman, Syed M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (04) : 663 - 669
  • [6] Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
    Richard L. Wasserman
    Joseph A. Church
    Mark Stein
    James Moy
    Martha White
    Steven Strausbaugh
    Harry Schroeder
    Mark Ballow
    James Harris
    Isaac Melamed
    David Elkayam
    William Lumry
    Daniel Suez
    Syed M. Rehman
    Journal of Clinical Immunology, 2012, 32 : 663 - 669
  • [7] Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura
    van der Meer, J. W. M.
    van Beem, R. T.
    Robak, T.
    Deptala, A.
    Strengers, P. F. W.
    VOX SANGUINIS, 2011, 101 (02) : 138 - 146
  • [8] EFFICACY OF INTRAVENOUS IMMUNOGLOBULIN IN PRIMARY HUMORAL IMMUNODEFICIENCY DISEASE
    CUNNINGHAMRUNDLES, C
    SIEGAL, FP
    SMITHWICK, EM
    LIONBOULE, A
    CUNNINGHAMRUNDLES, S
    OMALLEY, J
    BARANDUN, S
    GOOD, RA
    ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) : 435 - 439
  • [9] Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
    Borte, Michael
    Pac, Malgorzata
    Serban, Margit
    Gonzalez-Quevedo, Teresa
    Grimbacher, Bodo
    Jolles, Stephen
    Zenker, Othmar
    Neufang-Hueber, Jutta
    Belohradsky, Bernd
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (05) : 752 - 761
  • [10] Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency
    Michael Borte
    Malgorzata Pac
    Margit Serban
    Teresa Gonzalez-Quevedo
    Bodo Grimbacher
    Stephen Jolles
    Othmar Zenker
    Jutta Neufang-Hueber
    Bernd Belohradsky
    Journal of Clinical Immunology, 2011, 31 : 752 - 761